Strumento inattivo

Altre lingue NovAccess Global Inc. Other OTC

Azioni

XSNX

US67001N1072

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

NovAccess Global : Material Agreement Form 8 K	04/06
NovAccess Global Inc. announced that it has received $0.009 million in funding	31/05
NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform	21/05
NovAccess Global Inc. acquired 18.60% stake in Fendix Media Ltd from David Sumner for $0.12 million.	17/05
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	15/05
NovAccess Global Inc. announced that it has received $0.1053 million in funding from AJB Capital Investments LLC	13/05
NovAccess Global : Announces New License to Advance its Immunotherapy Platform	30/04
NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC	29/04
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	27/02
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC	27/02
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/02
NovAccess Global Announces $10.7 Million Financing	03/01
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	01/12
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board	10/11
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.	01/09/23
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding	16/08/23
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11/08/23
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28/07/23
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	27/07/23
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue NovAccess Global Inc. Other OTC

Azioni

XSNX

US67001N1072

Altre lingue

Filtri